A universally conserved residue in the SUR1 subunit of the K ATP channel is essential for translating nucleotide binding at SUR1 into channel opening

Journal of Physiology

Volumn 590, Issue 20, 2012, Pages 5025-5036

  de Wet, Heidi ^a   Shimomura, Kenju ^a   Aittoniemi, Jussi ^a,b   Ahmad, Nawaz ^a   Lafond, Mathilde ^a   Sansom, Mark S P ^b   Ashcroft, Frances M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE DIPHOSPHATE MAGNESIUM; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MALTOSE BINDING PROTEIN; MUTANT PROTEIN; SULFONYLUREA RECEPTOR 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AND RELATED PHENOMENA; CHANNEL OPENING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE MUTATION; GENETIC CONSERVATION; HUMAN; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE BINDING; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; WILD TYPE;

EID: 84867473118     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.236075     Document Type: Article

References (38)

1. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL & Chang G (2009). Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718-1722.
2. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement IV JP, Boyd III AE, González G, Herrera-Sosa H, Nguy K, Bryan J & Nelson DA (1995). Cloning of the β-cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268, 423-426.
3. Ashcroft FM (2007). The Walter B Cannon Lecture. ATP-sensitive K-channels and disease: from molecule to malady. Am J Physiol Endocrinol Metab 293, E880-E889.
4. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M & Froguel P (2006). Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355, 456-466.
5. ATP channel. J Gen Physiol 132, 131-144.
6. ATP channel subunit Kir6.2. J Physiol 557, 347-354.
7. Dawson RJ & Locher KP (2006). Structure of a bacterial multidrug ABC transporter. Nature 443, 156-157.
8. Dawson RJ & Locher KP (2007). Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett 581, 935-938.
9. Dean M, Rzhetsky A & Allikmets R (2001). The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11, 1156-1166.
10. de Wet H, Mikhailov MV, Fotinou C, Dreger M, Craig TJ, Vénien-Bryan C & Ashcroft FM (2007a). Studies of the ATPase activity of the ABC protein SUR1. FEBS Journal 274, 3532-3534.
11. de Wet H, Rees M, Shimomura K, Aittoniemi J, Patch AM, Flanagan S, Ellard S, Hattersley AT, Sansom MSP & Ashcroft FM (2007b). Increased ATP-ase activity produced by mutations at R1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. Proc Natl Acad Sci U S A 104, 18988-18992.
12. de Wet H, Fotinou C, Amad N, Dreger M & Ashcroft FM (2010). The ATPase activities of sulphonylurea receptor 2A and sulphonylurea receptor 2B are influenced by the C-terminal 42 amino acids. FEBS J 277, 2654-2662.
13. ATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit. Proc Natl Acad Sci U S A 95, 13953-13958.
14. Edgar RC (2004). MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5, 113.
15. ATP channel activation by MgADP and diazoxide. EMBO J 16, 1145-1152.
16. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A 95, 7185-7190.
17. Hattersley AT & Ashcroft FM (2005). Activating mutations in Kir6.2 and neonatal diabetes: New clinical syndromes, new scientific insights and new therapy. Diabetes 54, 2503-2513.
18. Hollenstein K, Dawson RJ & Locher KP (2007). Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17, 412-418.
19. + channels. Neuron 16, 1011-1017.
20. + channel. J Biol Chem 271, 24321-24324.
21. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ & Higgins DG (2007). Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948.
22. ATP channel can result in either hyperinsulinism or neonatal diabetes. Diabetes 60, 1813-1822.
23. ATP channels by SUR1 and SUR2A. J Mol Cell Cardiol 39, 491-501.
24. Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, Nichols CG & Barbetti F (2007). An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 56, 328-336.
25. Matsuo M, Tanabe K, Kioka N, Amachi T & Ueda K (2000). Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B. J Biol Chem 275, 28757-28763.
26. ATP channels as molecular sensors of cellular metabolism. Nature 440, 470-476.
27. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP, Gonzales G, Aguilar-Bryan L, Permutt MA & Bryan J (1996). Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272, 1785-1787.
28. Proks P, Girard C & Ashcroft FM (2005). Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP. Hum Mol Genet 14, 2717-2726.
29. Proks P, Shimomura K, Craig TJ, Girard C & Ashcroft FM (2007). Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Hum Mol Genet 16, 2011-2019.
30. ATP channel by Mg-nucleotide interaction with SUR1. J Gen Physiol 136, 389-405.
31. 2+/ATP reveals a non-productive catalytic site. J Mol Biol 359, 940-949.
32. Sali A & Blundell TL (1993). Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234, 779-815.
33. ATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol 110, 643-654.
34. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, Steinkrauss L, Wanner L, Kaye R, Ruchelli E, Suchi M & Adzick NS (2004). Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 89, 288-296.
35. Tucker SJ, Gribble FM, Zhao C, Trapp S & Ashcroft FM (1997). Truncation of Kir6.2 produces ATP-sensitive K-channels in the absence of the sulphonylurea receptor. Nature 387, 179-183.
36. + channel gating and implications for channel inhibition by ATP. J Gen Physiol 112, 333-349.
37. 2+-independent ATP binding of the sulfonylurea receptor SUR1. J Biol Chem 272, 22983-22986.
38. + conductance. Neuron 31, 233-245.